Scarica l'app Stockscreener
1.35
6.25%
-0.09
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché JAGX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.44
Aprire:
$1.45
Volume 24 ore:
185.50K
Relative Volume:
0.90
Capitalizzazione di mercato:
$5.04M
Reddito:
$10.48M
Utile/perdita netta:
$-37.74M
Rapporto P/E:
-0.0834
EPS:
-16.1846
Flusso di cassa netto:
$-29.03M
1 W Prestazione:
+25.00%
1M Prestazione:
-22.86%
6M Prestazione:
-64.75%
1 anno Prestazione:
-94.46%
Intervallo 1D:
$1.32
$1.50
Intervallo di 1 settimana:
$1.05
$1.50
Portata 52W:
$1.00
$33.25
Jaguar Health Inc Stock (JAGX) Company Profile
Nome
Jaguar Health Inc
Settore
Industria
Telefono
415-371-8300
Indirizzo
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Confronta JAGX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
1.35 | 5.38M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-07-11 | Iniziato | Rodman & Renshaw | Buy |
Jaguar Health Inc Borsa (JAGX) Ultime notizie
Jaguar Health Executes Strategic Stock Exchange Agreements - TipRanks
FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs - The Florida Times-Union
Jaguar Health Inc (JAGX) is looking forward to a strong quarter - setenews.com
Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders - azcentral.com and The Arizona Republic
Jaguar Health Secures New Patent for Crofelemer in Short Bowel Syndrome, Strengthening Global IP Position Ahead of Additional Clinical Milestones - The Florida Times-Union
FDA extends conditional approval for Jaguar Health’s canine drug By Investing.com - Investing.com Australia
FDA extends conditional approval for Jaguar Health’s canine drug - Investing.com
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts - Daytona Beach News-Journal
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - Bluffton Today
Jaguar Health announces promising trial results for crofelemer - MSN
Jaguar Health Announces Promising Trial Results for Crofelemer - TipRanks
Jaguar Health (NASDAQ: JAGX) clears all special meeting items, notes MVID trial progress - Stock Titan
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue - Livingston Daily
REMINDER: Jaguar Health to Conduct Fireside Chat 9AM ET June 10 as Part of Lytham Partners’ Spring 2025 Spotlight Series - Daily Commercial
Sakthi Sugars Limited (SAKHTISUG) vs yyyFibonacci Extensions & Free Gain Edge With Data - earlytimes.in
JAGX S-3/A及美國證券交易委員會申報文件 - Yahoo 財經
How dovish Fed policy supports Jaguar Health Inc. (1JA0) stockJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - Newser
Is Jaguar Health Inc. stock near bottom after declineWeekly Gains Summary & Weekly Sector Rotation Insights - Newser
Jaguar Health (JAGX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Jaguar Health, Inc. (JAGX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
JAGX S-3及美國證券交易委員會申報文件 - Yahoo 財經
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates - Montgomery Advertiser
Is Jaguar Health Inc (JAGX) positioned for future growth? - Setenews
How Jaguar Health Inc. (1JA0) stock responds to job market shiftsDip Buying & Fast Gain Stock Tips - Newser
Jaguar Health Inc Azioni (JAGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):